HIF1A and Sepsis: Overall, HIF-1 holds substantial promise as a potential therapeutic target for sepsis and acute lung injury, with capacity to improve clinical outcomes through multiple mechanisms, including metabolic reprogramming, inflammatory response regulation, and vascular repair.